Infinity Pharmaceuticals Inc (INFI.OQ)
INFI.OQ on NASDAQ Stock Exchange Global Select Market
2.58USD
9:00pm BST
2.58USD
9:00pm BST
Change (% chg)
$0.11 (+4.45%)
$0.11 (+4.45%)
Prev Close
$2.47
$2.47
Open
$2.39
$2.39
Day's High
$2.64
$2.64
Day's Low
$2.39
$2.39
Volume
73,433
73,433
Avg. Vol
76,110
76,110
52-wk High
$3.13
$3.13
52-wk Low
$1.67
$1.67
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jun '18 | 0.00 | -0.124 |
| Mar '18 | 0.00 | -0.182 | |
| FY 2017 | Dec '17 | 0.00 | 1.324 |
| Sep '17 | 6.00 | -0.140 | |
| Jun '17 | 0.00 | -0.336 | |
| Mar '17 | 0.00 | -0.208 | |
| FY 2016 | Dec '16 | 0.00 | -0.458 |
| Sep '16 | 0.00 | -0.393 | |
| Jun '16 | 9.47 | 1.072 | |
| Mar '16 | 9.26 | -0.824 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 3 | 0.67 | 2.00 | 0.00 | 29.70 |
| Quarter Ending Mar-19 | 2 | 11.00 | 22.00 | 0.00 | -- |
| Year Ending Dec-18 | 3 | 0.67 | 2.00 | 0.00 | 29.67 |
| Year Ending Dec-19 | 3 | 7.33 | 22.00 | 0.00 | 0.00 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 3 | -0.14 | -0.10 | -0.20 | -0.49 |
| Quarter Ending Mar-19 | 3 | -0.05 | 0.18 | -0.22 | -- |
| Year Ending Dec-18 | 3 | -0.60 | -0.51 | -0.75 | -1.50 |
| Year Ending Dec-19 | 3 | -0.52 | -0.24 | -0.88 | -0.97 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 86.20 | 32.69 | |
| P/E High - Last 5 Yrs. | -- | 290.01 | 45.21 | |
| P/E Low - Last 5 Yrs. | -- | 90.56 | 23.82 | |
| Beta | 2.69 | 0.93 | 0.88 | |
| Price to Sales (TTM) | -- | 123.88 | 5.82 | |
| Price to Book (MRQ) | 1.36 | 15.34 | 4.90 | |
| Price to Tangible Book (MRQ) | 1.37 | 14.54 | 6.53 | |
| Price to Cash Flow (TTM) | -- | 70.75 | 22.98 | |
| % Owned Institutions | 71.60 | 13.94 | 2.14 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.34 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 0.24 | 1.52 | |
| Dividend 5 Year Growth Rate | -- | 2.56 | 5.38 | |
| Payout Ratio(TTM) | -- | 16.91 | 43.96 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -100.00 | 391.55 | 7.73 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -100.00 | 73.89 | 5.32 | |
| Sales - 5 Yr. Growth Rate | -27.39 | 30.83 | 9.89 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -131.35 | 24.83 | 22.57 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -581.56 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 37.95 | 10.95 | |
| Capital Spending - 5 Yr. Growth Rate | -15.59 | 38.70 | 14.94 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.94 | 2.25 |
| Current Ratio (MRQ) | 6.29 | 5.32 | 3.05 |
| LT Debt to Equity (MRQ) | 35.31 | 35.04 | 12.63 |
| Total Debt to Equity (MRQ) | 36.09 | 36.85 | 16.96 |
| Interest Coverage (TTM) | -- | -97.99 | 37.54 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 40.03 | 54.92 | |
| Gross Margin - 5 Yr. Avg. | -- | 49.23 | 52.45 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -146.16 | -574.53 | 11.10 | |
| Operating Margin (TTM) | -- | -770.03 | 4.36 | |
| Operating Margin - 5 Yr. Avg. | -101.91 | -594.78 | 6.45 | |
| Pre-Tax Margin (TTM) | -- | -731.81 | 5.41 | |
| Pre-Tax Margin - 5 Yr. Avg. | -104.77 | -600.11 | 6.89 | |
| Net Profit Margin (TTM) | -- | -732.73 | 1.68 | |
| Net Profit Margin - 5 Yr. Avg. | -104.92 | -603.07 | 3.14 | |
| Effective Tax Rate (TTM) | -- | 23.70 | 23.23 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.84 | 24.11 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 0 | 22,887,281 | 812,879,200 | |
| Net Income/Employee (TTM) | -3,037,261 | 1,727,321 | 95,609,515 | |
| Receivable Turnover (TTM) | -- | 19.88 | 5.78 | |
| Inventory Turnover (TTM) | -- | 2.39 | 3.60 | |
| Asset Turnover (TTM) | 0.00 | 0.40 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -50.23 | -0.96 | 10.94 | |
| Return on Assets - 5 Yr. Avg. | -26.43 | 3.30 | 12.05 | |
| Return on Investment (TTM) | -62.67 | 0.73 | 14.32 | |
| Return on Investment - 5 Yr. Avg. | -30.82 | 2.37 | 15.66 | |
| Return on Equity (TTM) | -78.61 | 1.82 | 16.04 | |
| Return on Equity - 5 Yr. Avg. | -41.07 | 3.23 | 16.92 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -82.83 | -- | -27.39 |
| EPS (TTM) % | 76.80 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Infinity Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 31.40 | 26.87 | 89 | 60 |
| 13 Week | 5.30 | 0.17 | 60 | 64 |
| 26 Week | -34.30 | -39.29 | 18 | 77 |
| 52 Week | 3.25 | -12.49 | 54 | 47 |
| YTD | 17.78 | 3.43 | 58 | 56 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 49.89% |
| # of Holders: | 77 |
| Total Shares Held: | 28,362,103 |
| 3 Mo. Net Change: | -5,405 |
| # New Positions: | 0 |
| # Closed Positions: | 0 |
| # Increased Positions: | 0 |
| # Reduced Positions: | 1 |
| # Net Buyers: | -1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.